MCOT

By Brian Dolan May 20, 2014
Medical device giant Medtronic is in the final stages of acquiring peel-and-stick medical sensor company Corventis for north of $150 million, MobiHealthNews has learned. While neither company has publicly commented on the deal, it is expected to be officially announced some time in the next few weeks. (Update: I've heard conflicting reports from sources on the price of the deal since publishing...
By Jonah Comstock November 20, 2012
The MCOTos, released earlier this year. CardioNet, one of the oldest companies in the mobile cardiac arrhythmia monitoring space, announced the launch of a new product last week, the wEvent wireless event monitor. "This new wireless device provides physicians a much improved replacement to their traditional event monitor," CEO Joseph Capper said in a statement. "The wEvent, unlike existing event...
By Brian Dolan February 7, 2012
CardioComm ECG Monitor CardioComm Solutions and TZ Medical inked a device integration and distribution deal that brings the pair into the the mobile cardiac telemetry (MCT) electrocardiographic (ECG) and arrhythmia management market. CardioComm will integrate TZM's Aera CT MCT monitor into its GEMS software to create a new offering called GEMS Aera CT. It will be an extension of CardioComm's...
By Brian Dolan July 7, 2010
More bad news on the reimbursement front for CardioNet and other mobile cardiac outpatient telemetry service providers: United Healthcare told the company that it is maintaining its position that “outpatient cardiovascular telemetry is unproven for managing cardiac arrhythmias" and as a result it will not cover the service for its members. CardioNet, of course, disagrees and promised to continue...
By Brian Dolan February 3, 2010
We reported earlier this week that Houston, TX-based wireless cardiac monitoring startup, eCardio had monitored about 20,000 patients to date. Today, CardioNet, one of the first wireless cardiac companies to go to market has announced that it just passed 300,000 patients monitored by its Mobile Cardiac Outpatient Telemetry (MCOT) service. “With 300,000 patients having now benefited from our MCOT...
By Brian Dolan February 2, 2010
Wireless remote monitoring for patients with heart conditions is fast becoming a crowded space for wireless health companies -- CardioNet, the only pureplay wireless health company to have gone public and LifeWatch, a Switzerland-based company are just two of the big players in this ever popular field. Last month we noted that Corventis had received FDA approval for its MCOT system, which put it...
By Brian Dolan January 19, 2010
Big news for the first startup shepherded by the West Wireless Health Institute: The FDA has greenlit Corventis' Nuvant system, a mobile cardiac telemetry system. The 510(k) clearance for Nuvant enables Corventis to begin marketing the service in the U.S. -- Corventis secured FDA clearance for its PiiX sensor (pictured), which is a part of the Nuvant system -- last April. According to the company...
By Brian Dolan October 28, 2009
CardioNet's 15th patent: In a recent press release, Randy Thurman, CardioNet Chairman, President and CEO, stated: "A key to success in delivering wireless medicine is rooted in our ability to distill the wide variety of information collected from sensors on the body and make that data useful for clinicians or other healthcare providers. With MCOT, we provide electrocardiogram and trended heart...
By Brian Dolan September 1, 2009
Highmark Medicare Services (HMS) confirmed with remote monitoring service provider CardioNet that the reduced reimbursement rate for mobile cardiovascular technology will become effective today, September 1, 2009. The new rate is $754 per service and that represents a 33 percent reduction from the $1,123 reimbursement rate the service has retained all year. "We are very disappointed at HMS'...
By Brian Dolan July 14, 2009
It's been a tough couple of months for wireless arrhythmia monitoring company CardioNet: The company has terminated its plans to acquire Minnesota-based Biotel, which has its own cardiac arrhythmia monitoring business, an experienced design and development team plus manufacturing capabilities that were set to support CardioNet's growing business. The deal was originally pegged at $14 million but...

Editor's Pick